Taken all together, we suggest that the ubiquitin–proteasome pathway-mediated Mcl-1 downregulation and miR-216a-5p-mediated DR5 upregulation have a critical role in autophagy inhibitor (lucanthone)-mediated sensitization of cancer cells to TRAIL-induced apoptosis. This evidence concerns the gene MCL1 and cancer.